Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease
Open Access
- 30 April 2005
- journal article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 11 (4), 307-313
- https://doi.org/10.1016/j.bbmt.2005.01.011
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Chronic graft-versus-host diseaseTransplantation and Cellular Therapy, 2003
- Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trialBlood, 2002
- Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone aloneBlood, 2002
- Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapseBlood, 2002
- Development of a prognostic model for grading chronic graft-versus-host diseaseBlood, 2001
- Transplantation of Bone Marrow as Compared with Peripheral-Blood Cells from HLA-Identical Relatives in Patients with Hematologic CancersNew England Journal of Medicine, 2001
- Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantationBone Marrow Transplantation, 2000
- Chronic graft-versus-host disease: is there an alternative to the conventional treatment?Bone Marrow Transplantation, 2000
- MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTSTransplantation, 1995
- Chronic graft-versus-host syndrome in manAmerican Journal Of Medicine, 1980